Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

CeriBell, Inc. (CBLL) Cash Flow Statement

CeriBell, Inc. (CBLL) generated -$54.0M of operating cash flow over the twelve months to 2026-06-30, spent $690000 on capital expenditure and had free cash flow of -$54.7M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CBLLCeriBell, Inc.Follow CBLL — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
1.0B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
3 Nov, in 10 days
LineFY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-35.0-40.8-54.0
Capital expenditure1.30.8-0.7
Free cash flow-36.4-41.6-54.7
Dividends paid0.00.0—
Stock-based compensation5.412.2—

USD millions · SEC XBRL

CeriBell, Inc. — questions

What is CeriBell, Inc.'s operating cash flow?
-$54.0M over the twelve months to 2026-06-30.
How much does CeriBell, Inc. spend on capital expenditure?
$690000 over the twelve months to 2026-06-30.
What is CeriBell, Inc.'s free cash flow?
-$54.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from CeriBell, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.